Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roland Giesen

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Deutsche Medizinische Wochenschrift (1946)|November 26, 2021
[Clinical benefit of Tocilizumab and other immunomodulating agents for treatment of COVID-19]Daniel Hornuss, Roland Giesen, Paul Biever, et al.
Emerging Infectious Diseases|September 25, 2024
Prosthetic Valve Endocarditis Caused by Pasteurella dagmatis, GermanyFelix A Rottmann, Peter Schorle, Roland Giesen, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 14, 2026
Possible quality indicators for clinical infectious diseases consultations - results from a hybrid Delphi-nominal group approach and scenario studyDaniel Hornuss, Philipp Mathé, Roland Giesen, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 15, 2024
An in-depth analysis of antimicrobial prescription quality in 10 non-university hospitals, in southwest Germany, 2021Gesche Först, Roland Giesen, Geertje Fink, et al.
Plos Medicine|January 23, 2025
Persistent symptoms and clinical findings in adults with post-acute sequelae of COVID-19/post-COVID-19 syndrome in the second year after acute infection: A population-based, nested case-control studyRaphael S Peter, Alexandra Nieters, Siri Göpel, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Deutsche Medizinische Wochenschrift (1946)|November 26, 2021
[Clinical benefit of Tocilizumab and other immunomodulating agents for treatment of COVID-19]Daniel Hornuss, Roland Giesen, Paul Biever, et al.
Emerging Infectious Diseases|September 25, 2024
Prosthetic Valve Endocarditis Caused by Pasteurella dagmatis, GermanyFelix A Rottmann, Peter Schorle, Roland Giesen, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 14, 2026
Possible quality indicators for clinical infectious diseases consultations - results from a hybrid Delphi-nominal group approach and scenario studyDaniel Hornuss, Philipp Mathé, Roland Giesen, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 15, 2024
An in-depth analysis of antimicrobial prescription quality in 10 non-university hospitals, in southwest Germany, 2021Gesche Först, Roland Giesen, Geertje Fink, et al.
Plos Medicine|January 23, 2025
Persistent symptoms and clinical findings in adults with post-acute sequelae of COVID-19/post-COVID-19 syndrome in the second year after acute infection: A population-based, nested case-control studyRaphael S Peter, Alexandra Nieters, Siri Göpel, et al.
Pageof 1